CMA Invites Views From Interested Parties On Roche, LumiraDx Deal
The UK's Competition and Markets Authority or CMA said on Monday that it decided to investigate the planned acquisition by Roche Diagnostics Limited ((RHHBY)) of certain entities held by LumiraDx Group Limited (LMDX) and LumiraDx International Limited. …